Stay up to date on all things ATS 2026 International Conference. Check out latest news, key deadlines, and exciting program updates below. Don’t miss a beat… and see you in Orlando, May 15-20, 2026!
-
Register Today for a “Magical” ATS 2026 International Conference in Orlando
on 2026-01-15Early registration is officially open for the ATS 2026 International Conference, May 15-20, in Orlando. Taking advantage of the early registration period not only ensures a place at the world’s most important respiratory medicine conference but also guarantees registrants the lowest rates and secure lodging. The deadline for early registration is Thursday, March 12.
-
Giving Back in Orlando: How the ATS Is Supporting the Local Community
on 2026-01-15Each year, the ATS leaves a lasting positive impact on its International Conference host city through community partnerships and service-oriented initiatives that seek to enrich the lives and overall health of its residents. In Orlando, attendees of the ATS 2026 International Conference will have multiple opportunities to serve the Boys & Girls Club of Central Florida and the LGBT+ Center Orlando.
-
Apply Now for $10,000 BEAR Cage Competition Grand Prize
on 2026-01-15Early-stage investigators with big ideas can apply today for the 12th Annual BEAR Cage Competition at the ATS 2026 International Conference. The top three submissions, selected by The ATS Drug Device Discovery and Development (DDDD) Committee, will compete for the $10,000 grand prize in front of a live audience at ATS 2026. Proposals for the competition are due by Monday, Feb. 9.
-
Clinical Year in Review Series Begins with Insights on Asthma, Interventional Pulmonary, Pulmonary Function Tests, and Sleep
on 2025-05-30The first session of the Clinical Year in Review series began with an exploration of evolving concepts and practice-changing studies in asthma, interventional pulmonary medicine, pulmonary function tests, and sleep medicine on Sunday, May 18, at the ATS 2025 International Conference.
-
Second Clinical Year in Review Session Explores Practice-Changing Findings and Emerging Concepts in General Critical Care, Sepsis, and More
on 2025-05-30The Clinical Year in Review series continued at ATS 2025 San Francisco with an examination of studies with clinical practice implications, and a closer look at unresolved questions in general critical care, acute respiratory distress syndrome, and more on Monday, May 19.
-
Third Clinical Year in Review Session Traces the Leading Edge in Bronchiectasis, Interstitial Lung Disease, Lung Transplant, and Pulmonary Infections
on 2025-05-30Deep dives into the latest research and therapeutic advances in bronchiectasis, interstitial lung disease, lung transplant, and pulmonary infections were the focus of the third Clinical Year in Review series session on Tuesday, May 20, at ATS 2025 San Francisco.
-
Final Clinical Year in Review Session Highlights Advances in COPD, Pulmonary Vascular Disease, Pulmonary Rehabilitation, and Lung Cancer
on 2025-05-30The Clinical Year in Review series at the ATS 2025 International Conference concluded on Wednesday, May 21, with a discussion of impactful studies spanning pulmonary vascular disease, COPD, pulmonary rehabilitation, and lung cancer.
-
Experts Encourage ATS Attendees to Take Action for Air Quality at Tuesday's Keynote
on 2025-05-21A panel of experts challenged ATS members and ATS 2025 International Conference attendees to help patients and regional leaders understand and act on the increasing importance of air quality for individuals and community health during the Keynote Series session, “Improving Air Quality and Health: Current Challenges and Opportunities."
-
Plenary Speaker Recounts Resilient Journey After Alpha-1 Antitrypsin Deficiency Diagnosis
on 2025-05-21Len Geiger was the featured speaker at the ATS 2025 International Conference Plenary Session. Diagnosed with Alpha-1 antitrypsin deficiency in 1994, Mr. Geiger has turned his personal health journey into a mission to educate, inspire, and drive meaningful change for others.
-
President’s Symposium Explores Many Facets of Underdiagnosed Alpha-1 Antitrypsin Deficiency
on 2025-05-21The “ATS President’s Symposium: Alpha-1 Breakthroughs: New Discoveries in Mechanisms, Diagnosis & Treatment of Lung Disease in Alpha-1 Antitrypsin Deficiency” examined critical gaps in knowledge about the disease at ATS 2025 San Francisco.